Thursday, January 23, 2020

T-6

Northwestern first site open for spinal cord stem cell trial

Published: September 22, 2010 | Spinal Cord Injury: , , , , , , ,

Northwestern Medicine is the first site open for enrollment in a national clinical research trial of a human embryonic stem cell-based therapy for participants with a subacute thoracic spinal cord injury. Following the procedure, participants will receive rehabilitation treatment at The Rehabilitation Institute of Chicago (RIC).

Northwestern also is the lead site of the trial, sponsored by Geron Corporation (Nasdaq: GERN). The trial eventually will include up to six other sites and enroll up to 10 participants nationally.

Do NOT follow this link or you will be banned from the site!